Target intelligence / Profile preview

Transient receptor potential cation channel subfamily V members 2, 3, and 4 (TRPV2/3/4)

Target
TRPV2/3/4
Molecular classification
Ion channel, Transient receptor potential channel, Vanilloid subfamily, Receptor
01

Overview

The TRPV2/TRPV3/TRPV4 group consists of three distinct non-selective cation channels within the vanilloid subfamily of the transient receptor potential (TRP) superfamily [1]. These channels are critical sensory transducers that respond to a variety of physical and chemical stimuli, including temperature, mechanical stress, and osmotic pressure [2]. TRPV2 is involved in high-threshold thermosensation and immune cell functions, while TRPV3 is predominantly expressed in skin keratinocytes where it regulates hair growth and barrier integrity [1, 3]. TRPV4 serves as a versatile mechanosensor and osmosensor, playing key roles in vascular tone, bone homeostasis, and lung fluid balance [2, 4]. Dysregulation of these channels is implicated in numerous pathologies, such as chronic pain, inflammatory skin diseases (e.g., atopic dermatitis), skeletal dysplasias, and pulmonary edema [3, 5]. Pharmacological modulation, particularly through small-molecule antagonists like GSK2798745, is a major area of drug development for treating respiratory, dermatological, and musculoskeletal disorders [5].

Other names
TRPV2TRPV3TRPV4Vanilloid receptor-like protein 1Vanilloid receptor-like protein 3Vanilloid receptor-like protein 2VRL-1VRL-3VRL-2OTRPC4VR-OACTRP12
02

Mechanism of action

These channels are primarily targeted by small-molecule antagonists to inhibit calcium influx and downstream signaling pathways associated with pain, inflammation, and fluid homeostasis. Some compounds, such as cannabidiol, act as agonists that can lead to channel desensitization, while others like tranilast specifically inhibit channel activity to treat allergic and inflammatory conditions.

03

Biological functions

ThermosensationMechanosensationOsmosensationCalcium signalingSkin homeostasisImmune responseVascular tone regulationBone homeostasis
04

Disease associations

InflammationPainAtopic dermatitisSkeletal dysplasiaPulmonary edemaCancerPruritusCardiomyopathyMuscular dystrophy
05

Safety considerations

Thermoregulatory disturbancesAltered bone remodelingVascular permeability changesPotential for cardiac contractility issuesSkin barrier disruption
06

Interacting drugs

Cannabidiol

7 more in the full profile.

07

Biomarkers

TRPV2 expression levelTRPV3 expression levelTRPV4 expression levelInterleukin-31 (IL-31)Lung fluid accumulationBone mineral density

Beyond the preview

Go deeper on Transient receptor potential cation channel subfamily V members 2, 3, and 4 (TRPV2/3/4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transient receptor potential cation channel subfamily V members 2, 3, and 4 (TRPV2/3/4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call